These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4119906)

  • 1. Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).
    Lloyd HH; Dulmadge EA; Wilkoff LJ
    Cancer Chemother Rep; 1972 Oct; 56(5):585-91. PubMed ID: 4119906
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
    Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
    Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the effect of 5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4 (or 5) -carboxamide (NSC-45388) and 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) on the reproductive integrity of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Dixon GJ
    Cancer Chemother Rep; 1968 Dec; 52(7):725-32. PubMed ID: 5754670
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression of polyamine synthesis in L1210 leukemic mice during treatment with a potent antileukemic agent, 5-azacytidine.
    Heby O; Russell DH
    Cancer Res; 1973 Jan; 33(1):159-65. PubMed ID: 4118428
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine.
    Neil GL; Berger AE; Bhuyan BK; DeSante DC
    Cancer Res; 1976 Mar; 36(3):1114-20. PubMed ID: 56229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-azacytidine on phytohemagglutinin-stimulated horse lymphocytes and cultured mouse L929 cells.
    Zain BS; Adams RL; Imrie RC
    Cancer Res; 1973 Jan; 33(1):40-6. PubMed ID: 4118429
    [No Abstract]   [Full Text] [Related]  

  • 9. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA; Coulter D; Valeriote F; Vietti TJ
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Veselý J; Pískala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
    Momparier RL; Gonzales FA
    Cancer Res; 1978 Sep; 38(9):2673-8. PubMed ID: 79443
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA; Vietti T; Valeriote F
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic alterations of liver regeneration. 8. Enhanced synthesis of DNA in the liver of 5-azacytidine-treated rats subjected to partial hepatectomy.
    Cihák A; Seifertová M; Veselý J; Sorm F
    Int J Cancer; 1972 Jul; 10(1):20-7. PubMed ID: 4122456
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 5-azacytidine and 6-azauridine on the synthesis of DNA in embryonic mouse brain mitotic activity and migration of ventricular cells.
    Seifertová M; Cihák A; Veselý J
    Neoplasma; 1973; 20(3):243-9. PubMed ID: 4125218
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice.
    Covey JM; Zaharko DS
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):109-17. PubMed ID: 2578963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY; Le Pecq JB
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of adriamycin on the reproductive integrity of cultured leukemia L1210 and P388 cells.
    Wilkott LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1978 May; 60(5):1117-20. PubMed ID: 565414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities for the clinical use of 5-azacytidine].
    Veselý J; Cihák A
    Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dihydro-5-azacytidine on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Mar; 41(3):780-9. PubMed ID: 6161697
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
    Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
    Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.